Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats-Reference-Cited by-同舟云学术

Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats

Published:2007-04-05 Issue:12 Volume:52 Page:3455-3464
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Fujita Koji,Yoneda Masato,Wada Koichiro,Mawatari Hironori,Takahashi Hirokazu,Kirikoshi Hiroyuki,Inamori Masahiko,Nozaki Yuichi,Maeyama Shiro,Saito Satoru,Iwasaki Tomoyuki,Terauchi Yasuo,Nakajima Atsushi

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-007-9741-4.pdf

Reference45 articles.

1. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231

2. Farrell GC (2003) Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 18:124–138

3. Diehl AM, Goodman Z, Ishak KG (1988) Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95:1056–1062

4. Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434–438

5. Harrison SA, Kadakia S, Lang KA, Schenker S (2002) Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 97:2714–2724

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease;Current Obesity Reports;2023-07-05

2. Telmisartan-Loaded Lactosylated Chitosan Nanoparticles as a Liver Specific Delivery System: Synthesis, Optimization and Targeting Efficiency;AAPS PharmSciTech;2023-06-23

3. Effect of telmisartan on an experimental model of periodontitis in mice;Oral Diseases;2022-04-06

4. Telmisartan, an angiotensin II receptor blocker, attenuates Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-1β in murine macrophages;International Immunopharmacology;2019-10

5. Telmisartan attenuates N-nitrosodiethylamine-induced hepatocellular carcinoma in mice by modulating the NF-κB-TAK1-ERK1/2 axis in the context of PPARγ agonistic activity;Naunyn-Schmiedeberg's Archives of Pharmacology;2019-07-31